Effectiveness and safety of plasma exchange for anti-MDA5 antibody-positive clinically amyopathic dermatomyositis with rapidly progressive interstitial lung disease refractory to intensive immune suppression therapy: A case series.
Tomoka WatanabeMisaki TaniguchiSanae OguraMea AsouShunsuke TakayanagiYuko SokaiYoshiki TsujiKeita P MoriTomomi EndoToshiki NakajimaYoshitaka ImuraTatsuo TsukamotoPublished in: Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy (2024)
PEx might be a promising option for controlling the disease activity of anti-MDA5 Ab-positive CADM with severe RP-ILD and may contribute to better survival.
Keyphrases
- interstitial lung disease
- rheumatoid arthritis
- disease activity
- systemic sclerosis
- systemic lupus erythematosus
- rheumatoid arthritis patients
- breast cancer cells
- ankylosing spondylitis
- idiopathic pulmonary fibrosis
- juvenile idiopathic arthritis
- multiple sclerosis
- early onset
- cell cycle arrest
- stem cells
- cell proliferation
- drug induced
- replacement therapy